Red Sox’ Chris Sale to Undergo Tommy John Surgery

Red Sox ace left-hander Chris Sale will undergo Tommy John surgery on his left elbow, the team officially announced Thursday.

This news comes one day after it was reported by The Boston Globe’s Alex Speier that Sale had recently begun another throwing program in Fort Myers nearly three weeks after throwing to live hitters for the first time since last year at the beginning of the month.

The day after throwing that live bullpen session, Sale began to feel discomfort in the same left elbow he had issues with in 2019, and the results of his MRI revealed a flexor tendon strain. Those results were sent over to esteemed sports medicine specialists Dr. James Andrews and Dr. Neil ElAttrache, but neither doctor recommended surgery at the time and instead prescribed Sale with rest since his ulnar collateral ligament (UCL) was “unchanged”, per interim manager Ron Roenicke.

While speaking with reporters in a conference call on Thursday, Red Sox chief baseball officer Chaim Bloom explained that Sale began throwing again last Friday, then threw a light session on Sunday, but had to be shut down while throwing outside on Tuesday due to the pain he felt in that elbow. That’s how the decision for the left-hander to go under the knife was reached.

According to Bloom, the date for Sale’s surgery has not yet been set, but he does “expect it to be soon, in the fairly near future.”

The recovery time for a pitcher undergoing Tommy John surgery is typically anywhere between 12 to 15 months, so depending on when Sale does have it, he will miss the entirety of the 2020 season, whenever that starts, as well as some time in 2021.

Sale, who turns 31 later this month, is set to earn $30 million this season in the first year of the five-year, $145 million contract extension he signed with Boston last March.

The Florida native missed the final six weeks of the 2019 campaign due to inflammation in his left elbow and dealt with a bout of pneumonia right around the time camp broke this year.

Without Sale in their plans, the Red Sox’ starting rotation will be composed of Eduardo Rodriguez, Nathan Eovaldi, and Martin Perez. Outside of those three, Ryan Weber had looked solid in his handful of spring starts, while Roenicke also mentioned Brian Johnson and an opener as potential rotation options on Thursday.

“”It’s never just about one season. We’re always going to make sure we’ll bolster our long-term outlook as well,” Bloom said in regard to this year’s Red Sox. “Losing Chris for 2020 isn’t going to make our task any easier.”

Red Sox Renew Rafael Devers’ Contract for 2020 Season After Both Sides Fail to Reach Agreement

The Red Sox and third baseman Rafael Devers were unable to reach an agreement on a figure for his 2020 salary, meaning the club instead renewed the 23-year-old’s contract for the coming season.

According to The Boston Globe’s Alex Speier, Devers will earn approximately $692,5000 this year, about a 13% raise from the $614,500 he made in 2019.

The 2020 campaign will mark Devers’ final season before he becomes arbitration eligible next winter. From this point forward, the Dominican Republic native is under team control for four more years before he reaches free agency for the first time at the conclusion of the 2023 season.

Going back to late last September, it was reported by WEEI’s Rob Bradford that the Red Sox were planning on offering Devers a contract extension at some point during the offseason.

Since that time, as we know, the club had quite the winter, hiring Chaim Bloom as chief baseball officer in October, parting ways with Alex Cora in January, and trading Mookie Betts and David Price to the Dodgers and naming Ron Roenicke interim manager in February.

Those factors, in addition to the mandate of getting under the $208 million luxury tax threshold, more than likely pushed extension talks with Devers further down the to-do list.

“If it comes, it comes,” Devers said, through translator Bryan Almonte, of a potential contract extension. “That would be great. But I’m just focused on right now. We haven’t had discussions about that yet. My agent hasn’t told me anything. As of now, I’m just focused on playing the game.”

Devers is coming off a season in which he finished 12th in American League Most Valuable Player voting after slashing .311/.361/.555 with 32 home runs and 115 RBI over 156 games played in 2019.

In addition to renewing Devers’ contract on Monday, the Red Sox also reached agreements with 19 other pre-arbitration players on one-year deals for the 2020 season.

Those 19 players are Jonathan Arauz, Yoan Aybar, Ryan Brasier, Colten Brewer, Austin Brice, C.J. Chatham, Michael Chavis, Bobby Dalbec, Matt Hall, Kyle Hart, Darwinzon Hernandez, Tzu-Wei Lin, Chris Mazza, Mike Shawaryn, Josh Taylor, Alex Verdugo, Marcus Walden, Ryan Weber, and Marcus Wilson.

Verdugo, the centerpiece in the Betts and Price trade, will earn $601,500 in 2020, per Speier.

 

Red Sox Fail to Muster Any Offense in 5-0 Loss to Astros

After falling to the Tigers on Wednesday, the Red Sox saw their losing streak grow to three games on Thursday following a 5-0 defeat at the hands of the Houston Astros at JetBlue Park. They are now 4-8-2 in Grapefruit League play.

Making his first start and third overall appearance for Boston was Kyle Hart, coming off two scoreless innings of relief in his last time out against the Twins this past Friday.

Working the first three innings in this one, the left-hander surrendered two runs, both of which were earned, on three hits and two walks to go along with three strikeouts on the afternoon.

Both of those Astros runs came on one swing of the bat in the top half of the third, when after retiring six of the first nine hitters he faced, Hart yielded a one-out walk to Myles Straw and followed that up by serving up a two-run home run to Kyle Tucker.

That mistake gave Houston the only lead they would need, but Hart was able to rebound by getting the final two outs of the frame in order to end his outing on a more positive note.

As one of several candidates still vying for a spot in the Sox’ rotation, Hart, 27, will probably appear in another game sometime early next week.

In relief of Hart, Brandon Workman tossed a scoreless fourth inning and yielded one run on three hits and a sacrifice fly in the fifth before minor-leaguer Tom Windle came on and finished the inning for him.

From there, Marcus Walden sat down the only three hitters he faced in order in the sixth, left-hander Brian Johnson appeared to be on top of things in the seventh and eighth, but ended up being charged with two runs on three hits and a walk in the ninth before Konner Wade relieved him, allowed an inherited runner to score, and finished up the inning by getting Grae Kessinger to fly out to left.

All in all, Red Sox pitching combined to allow five earned runs on 12 hits, three walks, and 10 strikeouts over nine total innings pitched.

On the other side of things, a Red Sox starting lineup that featured plenty of regulars in Andrew Benintendi, Rafael Devers, Xander Bogaerts, J.D. Martinez, Michael Chavis, Christian Vazquez, Jackie Bradley Jr., Kevin Pillar, and Jose Peraza was matched up against Astros right-hander Josh James to begin things on Thursday.

Despite having all those regulars in the lineup though, the Boston bats could not muster much against James, or any other Houston pitcher they faced for that matter.

Five hits, only one of which went for extra base hits, one walk drawn, and one HBP. That’s it.

That lone extra base hit belonged to Michael Chavis, who doubled off James with one out in the second and was subsequently picked off by Garrett Stubbs at third on a failed stolen base attempt.

Other than that, the Sox sent three batters to hit in five of their nine trips to the plate on Thursday. Not much to write home about in what wound up being a 5-0 shutout loss.

Some observations from this defeat:

This game was not televised, so I really do not have much to add here, but I will say that the Red Sox went 0-for-2 with runners in scoring position on Thursday.

Xander Bogaerts in his first start at shortstop this spring: 0-for-2 with another pair of strikeouts.

Out of the 31 players the Astros sent from West Palm Beach for this contest, none were on the team in 2017, so from what I heard on the radio, there didn’t appear to be too many boos from the crowd at JetBlue Park.

Next up for the Red Sox, they’ll head to North Port to take on the Atlanta Braves at their new spring training facility on Friday afternoon.

Left-hander Eduardo Rodriguez is set to get the start for Boston, while Atlanta has yet to name a starter.

Rodriguez impressed in his spring debut against the Yankees last Saturday, fanning six over three scoreless innings at Fort Myers.

Matt Barnes, Colten Brewer, and R.J. Alvarez are among the Sox pitchers who will follow Rodriguez.

First pitch Friday is scheduled for 1:05 PM EST on ESPN.

Red Sox’ Chris Sale Has Flexor Strain

Red Sox ace left-hander Chris Sale has a flexor tendon strain in his left elbow, according to interim manager Ron Roenicke.

This news comes one day after Sale received a third opinion from Dr. Neil ElAttrache, after already getting a second opinion from Dr. James Andrews, in regard to the MRI of his sore left elbow.

Since his Ulnar Collateral Ligament (UCL) was “unchanged”, Sale has at least avoided surgery for the time being, as it was not recommended by either doctor. Instead, he has been prescribed rest and will not throw again for another week or so.

After that period of rest, Sale will begin throwing again and will need to be pain free while doing so. If he does still feel the same pain in his left elbow he experienced last year, then it might be time to assume the worst-case scenario.

“It sucks,” Sale said Thursday. “I know what I’m worth to this team and I don’t want to do anything stupid.”

The soon-to-be 31-year-old was already set to miss about the first two weeks of the 2020 season due to an earlier bout with pneumonia, but this setback will surely push his return date back even further depending on how things go at the end of next week.

This all comes as Sale enters the first year of the five-year, $145 million extension he signed with Boston last March. He will earn $25.6 million in 2020.

 

Red Sox Waiting for Another Opinion on Chris Sale’s Sore Left Elbow

One day after it was revealed that left-hander Chris Sale was dealing with soreness in his left elbow and an MRI had been sent to elbow specialist Dr. James Andrews, the Red Sox are now seeking a third opinion from another specialist in Dr. Neil ElAttrache, according to interim manager Ron Roenicke.

Sale reported the elbow soreness to the team’s medical staff on Monday, one day after throwing 15 pitches while facing live hitters for the first time since last August.

At that time, he was diagnosed with inflammation in his left elbow and received a platelet-rich plasma injection from Dr. Andrews that same month before eventually being shut down for the remainder of the 2019 campaign.

The Florida native was cleared to begin throwing again in late November, though, and outside of a bout with pneumonia, he seemed completely healthy otherwise headed into the spring. But now, it appears that his 2020 season could be in jeopardy.

Roenicke did say to not assume the worst-case scenario with Sale until the Red Sox have gathered all the necessary information, and he emphasized how they “want to get this right.”

Still, as The Boston Globe’s Pete Abraham notes, “teams usually don’t get a third opinion to confirm good news. Getting opinions from Andrews and ElAttrache certainly suggests there’s a significant injury.”

According to Roenicke, the Red Sox should have word from Dr. ElAttrache within “the next day or so.

Until then, stay tuned for more updates.

Red Sox’ Xander Bogaerts Set to Make Spring Debut Against Tigers

For the first time this spring, Red Sox shortstop Xander Bogaerts is set to make a Grapefruit League start.

Yes, after being sidelined with a sore left ankle since reporting to camp last month, the 27-year-old will serve as designated hitter and bat out of the three-hole for Boston against the Tigers at JetBlue Park on Wednesday.

Bogaerts initially suffered the injury while partaking in offseason workouts in his home country of Aruba back in early February, but he has progressed nicely over the past week or so.

“He’s pretty close to getting in a game,” interim manager Ron Roenicke said of Bogaerts Tuesday. “We’ll probably start him at DH. I guess he’s made a lot of progress over the last couple days.”

Lo and behold, Bogaerts is starting at DH for the Sox on Wednesday. He’ll probably get anywhere between two to three plate appearances.

And despite this setback, Bogaerts is still expected to be ready for Opening Day on March 26th.

Red Sox’ Chris Sale Dealing With Left Elbow Soreness

Red Sox ace left-hander Chris Sale is dealing with soreness in his left elbow, according to interim manager Ron Roenicke.

Per Roenicke, Sale first experienced the soreness on Monday, one day after facing live hitters for the first time since last August. He has since been sent for an MRI and the Red Sox are awaiting the results from Dr. James Andrews.

Sale, who turns 31 later this month, was already expected to begin the 2020 season on the injured list due to an earlier bout with pneumonia that would have delayed his spring preparations, but this recent news adds another layer of concern.

In that live batting practice session on a Fenway South backfield on Sunday, Sale threw 15 pitches while utilizing his entire pitch mix, and did not feel any pain in his arm upon the session’s completion.

Heading into what is now the first year of the five-year, $145 million extension he signed with Boston last March, Sale’s left elbow has received plenty of attention over the past 12 months.

The Florida native was shut down by the Sox due to inflammation in that same elbow last August, and he received a platelet-rich plasma (PRP) injection from Dr. Andrews later that same month.

He was eventually cleared to resume throwing right around Thanksgiving, though, and up until Tuesday morning, any developments related to his left arm seemed to be positive and encouraging.

With the results of the MRI yet to be revealed, it’s unclear on where things will go from here. Worst-case scenario is most likely season-ending surgery, but we really don’t know anything yet.

What we do know is that a Red Sox starting rotation that already faced plenty of skepticism will face even more if Sale is indeed sidelined for an even longer period of time than initially anticipated.